PDS Biotechnology Corp
PDSB· Nasdaq
PDSBPDS Biotechnology Corp
Filed Aug 13, 2020 · 10-Q · 44 days after period end · 0001140361-20-018339
| Metric | Q2 2020 | Q2 2019 | Q2 2018 | Q2 2017 |
|---|---|---|---|---|
| Net Income | -$2.93M | -$3.89M | -$567.83K | -$13.50M |
| EPS Diluted | -$0.19 | -$0.75 | -$0.17 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
PDS Biotechnology Corp · CIK 1472091 · Engraved from SEC EDGAR
ended Jun 30, 2020 · filed Aug 13, 2020 · 44 d after period end
